Dilantin, Lamictal carry risk of serious skin condition called SJS
The Epilepsy Foundation is warning people who take Dilantin or Lamictal to control their seizures that the medications can cause users to suffer from a rare but serious skin condition known as Stevens Johnson Syndrome (SJS).
Health Canada has ordered Pfizer Canada to issue stronger warnings about its smoking cessation medication Champix, also known as